Skip to main content
Clinical Trials/NCT05425407
NCT05425407
Completed
Not Applicable

A Randomized Double-blinded Placebo-controlled Study to Evaluate the Effect of Collagen Peptide (Collagen Peptan) Supplementation on Muscle and Tendon Damage, Repair, and Functional Capacity During Exercise Training Overload

KU Leuven1 site in 1 country22 target enrollmentApril 12, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Exercise
Sponsor
KU Leuven
Enrollment
22
Locations
1
Primary Endpoint
Change in maximal isometric knee-extension force of the right leg
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The aim of the study is to investigate the acute and short-term effects of collagen peptides (Collagen Peptan) on muscle and connective tissue during an eccentric overload training period. Currently, all studies investigating the effects of post-exercise collagen supplementation did this in the absence of whey proteins, which are part of the standard recommendations for post-exercise recovery. The investigators will therefore investigate whether the combined intake of whey proteins and collagen peptides ensures a better recovery of exercise performance and whether it can prevent or reduce symptoms of muscle and tendon overload during a three-week eccentric overload training period (n = 22).

Registry
clinicaltrials.gov
Start Date
April 12, 2021
End Date
June 30, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
KU Leuven
Responsible Party
Principal Investigator
Principal Investigator

Peter Hespel

Principal Investigator

KU Leuven

Eligibility Criteria

Inclusion Criteria

  • Sports participation, including general fitness training, between 2 and 5 hours max per week
  • Body mass index between 18.5 and 25

Exclusion Criteria

  • Any kind of injury/pathology that is a contra-indication to perform high-intensity exercise - Intake of any medication or nutritional supplement that could impact muscle protein synthesis and/or exercise performance during the period of the study
  • Intake of any whey protein, casein of branched-chain amino acid (BCAA) supplements from 1 month prior to the start of the study
  • Blood donation within 3 months prior to the start of the study
  • Current participation in another research trial
  • Any other argument to believe that the subject is unlikely to successfully complete the full study

Outcomes

Primary Outcomes

Change in maximal isometric knee-extension force of the right leg

Time Frame: Pretest - 48 hours after the first training session (day 3 of training intervention) - Posttest (day 22 of training intervention)

Change in maximal isometric knee-extension force (angle = 45°) of the right leg

Change in anteroposterior thickness of the right patellar tendon

Time Frame: Pretest - 48 hours after the first training session (day 3 of training intervention) - Posttest (day 22 of training intervention)

Change in anteroposterior thickness of the right patellar tendon

Change in countermovement jump performance

Time Frame: Pretest - 48 hours after the first training session (day 3 of training intervention) - Posttest (day 22 of training intervention)

Change in jump height when performing a countermovement jump, measured via a force platform

Change in neovascularization of the right patellar tendon

Time Frame: Pretest - 48 hours after the first training session (day 3 of training intervention) - Posttest (day 22 of training intervention)

Neovascularization of the right patellar tendon scored with the Modified Ohberg Score (range 0 - 4; the higher the score, the higher the degree of neovascularization).

Secondary Outcomes

  • Change in pain perception at the muscular level (VAS scale)(Training 1 (day 1 of training intervention) - Training 2 (day 3 of training intervention) - Training 8 (day 9 of training intervention) - Training 17 (day 19 of training intervention) - Posttest (day 22 of training intervention))
  • Change in the blood concentration of creatine kinase(Pretest - Training 2 (day 3 of training intervention) - Posttest (day 22 of training intervention))
  • Change in the blood concentration of Interleukin 6 (IL-6)(Pretest - Training 2 (day 3 of training intervention) - Posttest (day 22 of training intervention))
  • Change in the blood concentration of N-terminal propeptide of type I procollagen (P1NP)(Pretest - Training 2 (day 3 of training intervention) - Posttest (day 22 of training intervention))
  • Change in pain perception of the patellar tendon of the right leg (VISA-P)(Pretest - Training 1 (day 1 of training intervention) - Training 17 (day 21 of training intervention) - Posttest (day 22 of training intervention))

Study Sites (1)

Loading locations...

Similar Trials